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In conventional  T cells, the Tec family tyrosine kinase Itk is
required for signaling downstream of the T cell receptor (TCR). Itk
also regulates  T cell development, lineage commitment, and
effector function. A well established feature of Itk/ mice is their
inability to generate T helper type 2 (Th2) responses that produce
IL-4, IL-5, and IL-13; yet these mice have spontaneously elevated
levels of serum IgE and increased numbers of germinal center B
cells. Here we show that the source of this phenotype is  T cells,
as normal IgE levels are observed in Itk/Tcrd/ mice. When
stimulated through the  TCR, Itk/  T cells produce high levels
of Th2 cytokines, but diminished IFN. In addition, activated Itk/
 T cells up-regulate costimulatory molecules important for B cell
help, suggesting that they may directly promote B cell activation
and Ig class switching. Furthermore,wefind that T cells numbers
are increased in Itk/mice, most notably the V1.1V6.3 subset
that represents the dominant population of  NKT cells. Itk/ 
NKT cells also have increased expression of PLZF, a transcription
factor required for  NKT cells, indicating a common molecular
program between  and  NKT cell lineages. Together, these
data indicate that Itk signaling regulates  T cell lineage devel-
opment and effector function and is required to control IgE
production in vivo.
T cell development  T cell differentiation  T cell signaling
The Tec family tyrosine kinase Itk is important for signalingdownstream of the T cell receptor (1). In particular, Itk-
deficient T cells have defects in phospholipase C- (PLC-) phos-
phorylation, calcium mobilization, mitogen-activated protein ki-
nase (MAP kinase) activation, and AP-1 and nuclear factor of
activated T cells (NFAT) activation after T cell receptor (TCR)
stimulation. Itk is also critical for conventional  T cell develop-
ment, selection, and function. Of particular importance, Itk signal-
ing regulates CD4 T helper cell differentiation, playing a key role
in the development of Th2 responses (2). Based on this well-
documented defect of Itk/ mice in generating Th2 effector
responses and cytokine production, it was surprising to discover that
these mice had spontaneously elevated levels of serum IgE (3, 4),
as B cell isotype switching to IgE is highly dependent on Th2
cytokines IL-4 and IL-13 (5). As our previous studies had indicated
that Itk/  TCRNKT cells (referred to as NKT cells) were
also highly defective in producing effector cytokines such as IL-4
(6), we considered the possibility that  TCRNKT cells were the
major source of Th2 cytokines in Itk/ mice.
The  T cells are a highly conserved subset of T cells that
constitutes 1–5% of the lymphocytes in the blood and peripheral
organs of mice but can account for up to 50% of the lymphocytes
in the mucosal epithelia. As with other subsets of ‘‘innate’’ T
cells,  T cells express memory cell surface markers (7), and are
capable of rapidly secreting effector cytokines (8). Among the
many functions attributed to  T cells, a great deal of recent
interest has focused on their ability to modulate adaptive im-
mune responses, specifically the humoral response (9).
A variety of studies have indicated that  T cells are able to
provide help for B cell responses. Initial studies performed in
mice lacking  T cells showed that B cell expansion, differen-
tiation, and secretion of ‘T-dependent’ antibody isotypes, IgE,
and IgG1, were all intact in these mice (10). Furthermore,
TCR/ mice challenged repeatedly with parasitic infections
could produce germinal centers and generate increased antibody
production (11). Using a model of pulmonary allergic inflamma-
tion, decreased production of IgE and IgG1was seen inmice lacking
 T cells compared with WT mice (12). The  T cells have also
been shown to directly induce germinal center formation and Ig
hypermutation (13). Interestingly, even though the  T cells
expressing CD4 account for only 5–10% of all  cells, it is this
subset that appears to be responsible for inducing germinal centers
(14). Human  T cells have also been found in germinal centers;
these cells were found to up-regulateB cell costimulatorymolecules
such as CD40L, OX40, CD70, and inducible costimulatory mole-
cule (ICOS) in response to TCR stimulation (15, 16). Together,
these data indicate that  T cells can promote, either directly or
indirectly, the humoral immune response.
Here we show that, in the absence of Itk,  T cell differen-
tiation and effector function are dramatically altered. Itk/
mice contain increased numbers of CD4 and NK1.1  T cells
that normally constitute the NKT population (17). These cells
express PLZF, a transcription factor that uniquely defines 
NKT cells and is essential for normal  NKT cell development
(18, 19). As a consequence, Itk/  T cells produce robust
amounts of Th2 cytokines when stimulated, accompanied by
enhanced expression of cell surface receptors associated with B
cell help, such as ICOS and CD40L and thus promote a
spontaneous elevation in serum IgE levels. These data indicate
a surprising role for Itk in regulating the lineage development
and effector function of  T cells, particularly in controlling the
PLZF subset.
Results
 T Cells Promote the Hyper IgE and Enriched Germinal Center
Phenotype Seen in Itk/ Mice. In an effort to identify the cell type
producing Th2 cytokines and driving IgE class-switching and se-
cretion in unimmunized Itk/ mice, we considered  T cells. To
test this possibility, Itk/ mice were crossed to Tcrd/ mice (20)
that lack  T cells. As shown in Fig. 1A and reported previously (3,
4), Itk/ mice have elevated concentrations of serum IgE com-
pared with WT controls. Strikingly, in Itk/Tcrd/ double-
deficient mice, serum IgE levels drop significantly compared with
Itk/ mice. Similar results were seen upon analysis of the propor-
tion of germinal center phenotype B cells (B220 peanut agglutinin
[PNA]) (Fig. 1B). Individual cohorts of mice were tested at 2
months of age, 3.5 months of age, and 5 months of age, with similar
results.
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Itk-Deficient Mice Have Increased Numbers of  T Cells. The finding
that elevated serum IgE levels in Itk/mice were dependent on
 T cells suggested that the  T cells present in Itk/ mice
might be altered relative to their WT counterparts. We first
examined  T cell numbers. As seen in Fig. 1C, Itk/mice have
increased proportions of  T cells in the thymus, the spleen, the
mesenteric lymph nodes, and the liver, but not in the intestinal
intraepithelial lymphocyte (iIEL) compartment. A summary of
data indicates significant increases in the proportion and abso-
lute numbers of  T cells in both the thymus and the spleen, as
well as an increase in the percentage of  T cells in the liver, in
the absence of Itk (Fig. 1 D–F).
Itk/ Mice Contain Increased Proportions of  T Cells Subsets
Expressing V1.1V6.3, CD4, and NK1.1. Analysis of TCR chain
repertoires indicated an increased proportion in V1.1  T
cells in Itk-deficient versus WT mice, and a concomitant de-
crease in the other major subsets (V2 and V5) (Fig. 2 A and
B). Further, the majority of V1.1  T cells in the thymus and
liver of Itk/ mice also expressed V6.3 (Fig. 2C). Overall, we
find a significant increase in the absolute numbers of this  T
cell subset in thymus and spleen of Itk/ mice compared with
controls (Fig. 2 D and E), as well as an increased proportion of
V1.1V6.3  T cells in Itk/ liver (Fig. 2F). Interestingly,
V1.1V6.3  T cells are the predominant subset of  NKT
cells, and readily produce effector cytokines (17, 21, 22).
In contrast to WT  T cells, the Itk/  T cell population
shows a striking increase in the proportion of CD4 cells in the
thymus, spleen and liver (Fig. 3A and B). Itk/ mice also had
elevated proportions of thymic NK1.1  T cells (Fig. 3C and
D). Interestingly, the majority of the thymic Itk/ CD4  T
cells and virtually all of the thymic Itk/ NK1.1  T cells
express high levels of the memory cell marker CD44 (Fig. 3E),
as well as the activation marker CD69. As previously reported,
the majority of  T cells in the liver of WT mice are NK1.1
(i.e.,  NKT cells) (17), and this is also the case in Itk/ liver
(Fig. 3 C and D).
Focusing on the V1.1V6.3 subset of  T cells, we find
that WT and Itk/ mice each have a similar proportion of
NK1.1 CD4 cells, whereas NK1.1 CD4 cells are increased
substantially in Itk/ mice [supporting information (SI) Fig.
S1]. Furthermore, outside the thymus, the V1.1V6.3 subset
is found predominantly in the liver, rather than the spleen (Fig.
3 F and G), as has been reported previously for  NKT cells
(17). The  T cells not expressing V1.1V6.3 correspond to the
‘‘conventional’’ NK1.1CD4CD8 subset; this conventional 
T cell subset is not altered in numbers in Itk/ versus WT mice,
indicating that ITK controls the generation of ‘‘nonconven-
tional’’ CD4 or NK1.1, but not conventional,  T cells.
Expanded populations of CD4  T cells have been previ-
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Fig. 1.  T cells in Itk/mice are responsible for the spontaneous elevation in
serum IgE levels. (A) Serum obtained fromWT, Tcrd/, Itk/, and Itk/Tcrd/
micewereanalyzedfor IgEbyELISA. (B) Splenocytes fromWT,Tcrd/, Itk/, and
Itk/Tcrd/ mice were stained with -B220 Ab and PNA to identify germinal
centerB cells.DifferencesbetweenWTandTcrd/ (P0.14) andbetween Itk/
and Itk/Tcrd/ (P  0.54) were not statistically significant. (C) Cells were
prepared from thymus, spleen,mesenteric lymphnodes (mLN), intestinal epithe-
lium (iIELs), and liver and were stained with anti-TCR and anti-TCR Abs. (D–F)
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Fig. 2. Itk/micehave an increasedpopulationofV1.1V6.3T cells. (A)
Thymocytes and splenocytes were stained with antibodies to TCR and either
V1.1, V2, V3, and V5. Histograms show V staining on gated TCR cells.
(B) Lymphocytes were isolated from the liver and stained with antibodies to
TCR and V1.1 or V2. Histograms show V staining on gated TCR cells. (C)
Thymocytes, splenocytes, and liver cells were stainedwith antibodies to TCR,
V1.1 and V6.3. Dot plots show V1.1 vs. V6.3 staining on gated TCR T
cells. (D) Absolute numbers of V1.1V6.3  T cells in the thymus and spleen
and percentages of V1.1V6.3  T cells in the liver were compiled.
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ously demonstrated in mice lacking expression of both TCR
and CD5 (14). We therefore examined CD5 expression on Itk/
 T cells, to determine if altered levels of CD5 might be
contributing to the increased number of CD4  T cells in these
mice, but detected no differences between WT and Itk/ mice.
However, like a previously-reported subset of activated T cells
specific for self-ligands, the MHC class Ib molecules, T10/T22
(23), the NK1.1 subset of thymic Itk/  T cells are all
CD122-positive.
To determine whether the alterations we observed in Itk/mice
are intrinsic to the hematopoietic cells or to the environment, we
generated bonemarrow chimeras usingWT or Itk/ bonemarrow
cells. These experiments demonstrated that the increased propor-
tions of both  T cells and germinal center B cells seen in Itk/
mice are intrinsic to Itk/ hematopoietic cells (Fig. S2). Consistent
with these data, we also find that the predominant Tec kinase
expressed in WT  T cells is Itk (Fig. S3).
Enhanced Expression of IL-4 and PLZF in Itk-Deficient  T Cells. To
determine the basis for the altered function of Itk/  T cells,
we examined mRNA levels for T-bet, Eomesodermin, and
GATA-3 in WT versus Itk/  T cells. We found that Itk/
 T cells consistently expressed higher levels of GATA-3
mRNA and protein compared with WT  T cells, while the
NK1.1 subset of Itk/  T cells have reduced levels of mRNA
for both T-bet and Eomesodermin (Fig. S3). These findings
suggested that Itk/  T cells might produce a distinct pattern
of cytokines compared with WT  T cells. We first examined
mRNA levels for the signature cytokines, IL-4 and IFN, after
 T cell activation in vitro. As shown in Fig. 4A, in response to
 TCR stimulation, Itk/  T cells had constitutively elevated
levels of IL-4 mRNA before stimulation and exhibited dramat-
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Fig. 3. Altered  T cell subsets in the spleen and thymus of Itk/mice. Cells
were prepared from thymus, spleen, and liver of WT and Itk/ mice and
analyzed by flow cytometry. (A) CD4 vs. CD8 expression on gated TCRTCR
cells. The percentages of each subpopulation are indicated, and the mean
fluorescence intensities are shown in parentheses. (B) The percentages of
CD4TCR cells in the thymus, spleen, and liver are shown. (C) CD4 vs. NK1.1
expression on gated TCRTCR cells in the thymus, spleen, and liver. (D) The
percentages of NK1.1TCR cells in the thymus, spleen, and liver. (E) Thymic
TCRTCR cells were analyzed for CD44 vs. CD4 (top) or NK1.1 (bottom)
expression. Data are representative of two independent experiments. (F)
TCRTCR cells from the liver were analyzed for V1.1, V6.3, NK1.1, and
CD4 expression. Dot-plots show NK1.1 vs. CD4 expression on gated
V1.1V6.3 cells. (G) The percentages of total cells in the thymus, spleen,
and liver that represent the V1.1V6.3NK1.1 subset were calculated.
Differences between the WT and Itk/were statistically significant (thymus,
P  0.0006; spleen, P  0.0006; liver, P  0.001).
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peripheral CD8  T cells and  NKT cells were analyzed for comparison.
Data are representative of two independent experiments. (C) 5  104 cells
were stimulated with 10 g/ml of anti-TCR for 72 hours and supernatants
were analyzed for the presence of IL-4, IL-10, IL-13, and IFN by cytometric
bead array (CBA). Data are representative of three independent experiments.
(D) 3 104 cells were stimulated as in (B). Supernatants were analyzed for the
presence of IL-4, IL-10, IL-13, and IFN by CBA. Data are representative of two
independent experiments. (E) Nonstimulated (NS) and stimulated (P/I) WT
(left) and Itk/ (right)  T cells were analyzed for intracellular IL-4 and IFN-
production. Cells were stimulated with 10 ng/ml PMA and 2 g/ml Ionomycin
(P/I) for 4 hours. Data are representative of four independent experiments.
8310  www.pnas.orgcgidoi10.1073pnas.0808459106 Felices et al.
ically enhanced induction of IL-4 mRNA at 10 hours and 20
hours poststimulation compared withWT  T cells. Basal levels
of IFN mRNA were similar between the WT and Itk/  T
cells; after stimulation, both cell types produced IFN, although
WT  T cells showed higher levels of IFN mRNA compared
with  T cells lacking Itk.
Based on the high proportion of V1.1V6.3  T cells
present in Itk/ mice and the previous association of this  T
cell subset with dual production of IL-4 and IFN (21, 22), we
also examined WT and Itk/  T cells for expression of the
transcription factor PLZF. PLZF has recently been found to be
critical for the development and effector function of TCR
NKT cells, where it promotes the simultaneous production of
IL-4 and IFN (18, 19). Interestingly, we found that splenic
Itk/  T cells express substantially higher amounts of PLZF
mRNA than do WT  T cells (Fig. 4B). Furthermore, among
Itk/  T cells, the NK1.1 fraction expresses particularly high
levels of PLZF mRNA. These findings support the conclusion
that  T cell development is altered in the absence of Itk.
To assess levels of cytokine protein secretion, individual
subsets of Itk/ andWT T cells were purified and stimulated.
As previous studies have found that NK1.1  T cells and CD4
 T cells produce the highest levels of cytokines, particularly
‘‘Th2’’ cytokines (24–28), we compared NK1.1 to NK1.1, and
CD4 to CD4  T cell subsets. After 72 hours of stimulation,
WTNK1.1  T cells secreted more IL-4, IL-10, and IL-13 than
their NK1.1 counterparts; in contrast, both NK1.1 and
NK1.1 subsets ofWT  T cells secreted large amounts of IFN
(Fig. 4C). Consistent with the analysis of cytokine mRNA levels,
we observed elevated secretion of the Th2 cytokines IL-4, IL-10,
and IL-13 by the Itk/ NK1.1  T cells when compared with
WT NK1.1 cells; furthermore, Itk/ NK1.1  T cells
secretedmuch higher amounts of these cytokines per cell relative
to the Itk/ NK1.1 subset. In addition, we found that both
subsets of Itk/  T cells secreted IFN, but at a lower level
than the WT cells.
Comparison of the CD4 versus CD4 subsets of  T cells
confirmed previous data (27, 28) that  T cells expressing CD4
are the major cytokine-producing population, particularly for
the ‘‘Th2’’ cytokines. As shown in Fig. 4D, Itk/CD4 T cells
produce elevated levels of IL-4 and IL-13 compared with WT
CD4  T cells, but produce similar levels of IL-10. None of
these cytokines were detected in supernatants of stimulated
CD4  T cells from either Itk/ orWTmice. As noted above,
WT  T cells (both CD4 and CD4 subsets) secrete higher
levels of INF than Itk/  T cells.
On a population basis, Itk/  T cells secreted both IL-4 and
IFN after stimulation. To determine whether individual cells
were dual producers of both effector cytokines, we stimulated
WT and Itk/  T cells in vitro with phorbol 12-myristate
13-acetate (PMA) and ionomycin and then examined IL-4 and
IFN production by intracellular cytokine staining (Fig. 4E). As
expected, a larger proportion of WT  T cells produce IFN in
response to stimulation compared with those that produce IL-4,
and few cells produce both cytokines. In contrast, Itk/  T
cells include a significantly larger population that produces IL-4
than is seen in the WT  T cell subset (Itk/, 6.9  1.1; WT,
3.5  0.8; n  7; P  0.04); additionally, a greater proportion of
Itk/  T cells produces both IL-4 plus IFN compared with
WT  T cells (Itk/, 3.9 0.8; WT, 1.7 0.3; n 7; P 0.02).
Because this pharmacological stimulation bypasses the need for
ITK in TCR-mediated signaling, these data indicate that a larger
proportion of Itk/  T cells are programmed to produce IL-4,
as well as IL-4 plus IFN, before their activation. This latter
finding, together with the data demonstrating increased numbers
of CD4 and NK1.1  T cells in the Itk/ mice, strongly
suggests that  T cell development is altered in the absence of
Itk leading to a striking increase in a PLZF-positive, IL-4-
producing  T cell population.
Itk/  T Cells Up-Regulate Surface Receptors That Promote B Cell
Help. We next examined  T cells for the expression of co-
stimulatory molecules that provide B cell help, such as CD40L,
CD70, OX40, and ICOS (15). For these experiments, WT and
Itk/ thymocytes and splenocytes were evaluated directly ex vivo
and, in addition, were cultured for 24 hours in the presence of
stimulatory anti-TCR antibodies. Although analysis of splenic 
T cells fromWT and Itk/mice did not reveal any major changes
in co-stimulatory markers, we did see a small increase in the
proportion of constitutively ICOS-positive  T cells in the spleens
of Itk/mice. Inasmuch as Itk/mice have a two-fold increase in
the absolute number of total T cells in the spleen compared with
WT, this difference amounts to a 10-fold increase in ICOS-
positive splenic T cells, and thus could account for the enhanced
B cell activation observed in Itk/ mice.
More strikingly, levels of ICOS were increased on a large
proportion of the thymic Itk/  T cells compared with
controls, but remained unaltered following stimulation (Fig. 5A).
Evaluation of the ICOShi fraction of Itk/ thymic  T cells
indicated that nearly all of these cells were CD4, and a
substantial proportion were also NK1.1 (Fig. 5B). Little to no
difference was seen in the basal levels of CD40L and OX40 when
comparing thymic Itk/  T cells to WT  T cells directly ex
vivo (Fig. 5A). However, after 24 hours of in vitro stimulation on
anti-TCR–coated plates, Itk/ cells up-regulated both CD40L
and OX40, whereas WT  T cells did not. This up-regulation of
CD40L and OX40 was detected on all subsets of Itk/  T cells
(Fig. 5B). Finally, we could not detect expression of CD70 on
either WT or Itk/ thymic  T cells.
Discussion
Overall, our data indicate that  T cell development is signif-
icantly altered in the absence of Itk, yielding increased numbers
of  T cells and a shift in the major effector functions mediated
by these cells. Most strikingly, Itk/ mice have elevated num-
bers of  T cells expressing CD4 and NK1.1. Furthermore,
unlike the  T cells in WT mice, the Itk/  T cells secrete
large quantities of the Th2 cytokines, IL-4, IL-10, and IL13, in
addition to the IFN typically secreted by activated WT  T
cells, correlating with high levels of the transcription factor,
PLZF. These findings strongly suggest that Itk signaling plays a
key role in regulating  T cell lineage development.
Surprisingly, these altered  T cells are responsible for
promoting significant levels of spontaneous IgE secretion in
Itk/mice. Based on the findings presented here, it is likely that
the high levels of IL-4 and IL-13 produced by the activated Itk/
 T cells are a major factor in this response. Our data indicate
that activated Itk/ T cells express elevated amounts of B cell
co-stimulatory molecules, such as ICOS, CD40L, and OX40,
further suggesting that the  T cells may be directly providing
help to the B cells, leading to B cell activation and Ig class
switching.
In humans, a variety of studies have implicated  T cells in
allergic airway inflammation (29, 30) and, specifically, in promoting
B cell activation and IgE class switching (31, 32). One interesting
clinical report found that IL-4-producing  T cells were likely
responsible for a case of hyper IgE syndrome (33). Studies per-
formed in vitro with human  T cells showed that these cells, in
combination with IL-4, can induce B cell activation, Ig isotype
switching, and secretion of IgE (34). Further, these findings cor-
relate well with observations that human  T cells can express
ICOS, CD40L, OX40, and CD70 (15). Our data indicate that the
Tec family tyrosine kinase, Itk, plays a key role in regulating this
potentially highly detrimental function of  T cells.
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Recently, T cells have also been implicated in the elevated IgE
concentrations seen in mice carrying mutations in additional T cell
signaling proteins. For instance, in the absence of the E3-ubiquitin
ligase, Itch,  T cells secrete IL-4 and promote IgE production in
nonimmunized mice (29). More strikingly, mice expressing a mu-
tant allele of the adapter protein linker of activated T cells (LAT),
which lacks the three c-terminal tyrosines, succumb to a fatal
lymphoproliferative disorder that is mediated by  T cells (35). In
these LAT mutant mice, the  T cells accumulate to large
numbers, and show a phenotype remarkably similar to those lacking
Itk. For instance, the LAT mutant  T cells secrete IL-4, rather
than IFN-, and many of them express the CD4 co-receptor; in
addition, the mice also have elevated levels of serum IgE. As this
mutant LAT protein does not support T cell development, these
altered  T cells are the only source of T cell help for B cell
activation and IgE class switching. As Itk and LAT interact in a
TCR-dependent signaling complex in  T cells, the similarities in
the  T cell phenotype in these two lines of mice strongly suggest
that these proteins are also in the same signaling pathway down-
stream of the TCR, and furthermore, that this pathway regulates
the development and effector function of  T cells. As Itk has
previously been shown to suppress the development of innate 
lineage T cells and to promote the development of conventional 
T cells (36), a similar function for Itk may be required in  T cells;
thus, in the absence of Itk, enhanced development of innate (e.g.,
PLZF, NK1.1)  T cells occurs, leading to increased numbers
of effector cytokine-producing  T cells in Itk/ mice.
Interestingly, a recent report by Jensen et al. demonstrates that
 T cells, like  T cells, are found as both naïve and effector
subsets (23). Effector-type  T cells express higher levels of
CD44, NK1.1, and CD122 relative to the naïve subset and in
addition, show an altered cytokine secretion profile. Further-
more, the presence of the effector  T cell population corre-
lated with the expression of the TCR ligand for these  T cells,
indicating that ligand recognition was responsible for their
activated phenotype. As a large population of Itk/  T cells
exhibit a similar effector cell phenotype and produce effector
cytokines such as IFN- and IL-4; these findings suggest that
ligand recognition by Itk/  T cells may contribute to their
activation in vivo and their role in promoting IgE production in
nonimmunized mice.
These findings have substantial relevance to the potential
effects of small molecule inhibitors of Itk. Given the importance
of Itk in Th2 development and cytokine production by CD4 
T cells, this kinase is currently being targeted for the develop-
ment of drugs to treat asthma and other allergic diseases (5, 37).
It would be unfortunate if Itk inhibition also led to the aberrant
activation of  T cells and thus to enhanced production of IgE.
Elevated levels of serum IgE would, in turn, lead to up-
regulation of the FcRI on mast cells (38), promoting hyperre-
sponsiveness of these cells to IgE-mediated receptor aggrega-
tion. In light of the findings presented here, further studies on the
role of Itk in human  T cells are clearly warranted.
Materials and Methods
Mice. Itk/ mice (39) are on the C57BL/10 strain. Tcrd/ mice (20) on the
B57BL/6 background (Jackson Laboratories) were crossed to Itk/ mice to
obtain Itk/Tcrd/ mice. Wild-type mice were Itk/Tcrd/ littermates or
C57BL/10 mice (Jackson Laboratories). All mice used were 2–3 months of age
andweremaintained at theUniversity ofMassachusettsMedical School under
specific pathogen-free conditions after institutional animal care and use
committee approval.
Cell Preparations, Antibodies, and Flow Cytometry. Liver lymphocytes were
isolated by collagenase digestion of minced liver followed by Ficoll gradient
centrifugation; iIELs were isolated by incubation of cleaned intenstine followed
by Ficoll gradient centrifugation. The following antibodieswere purchased from
BD Pharmingen: TCR(GL3)-FITC, V2-FITC, V3-FITC, V6.2/6.3-PE, TCR-
allophycocyanin, TCR-PE, TCR-biotin (bio), CD4-allophycocyanin, CD4-PE,
CD8-PerCP-Cy5.5, NK1.1-PE-Cy7, CD5-CyChrome, IL-4-PE, IFN-allophycocyanin,
B220-allophycocyanin, streptavidin (strep)–allophycocyanin, and OX40-biotin.
TCR-allophycocyanin, ICOS-PE, and CD40L-allophycocyanin were purchased
from eBioscience. PNA-FITC was purchased from Vector Laboratories. Strep-
Cascade Yellow was purchased from Invitrogen Molecular Probes. V1.1-bio
was a kind gift from Lynn Puddington (University of Connecticut Health
Center, Storrs, CT). Cells (500,000–2,000,000 events) were collected on a LSRII
(BD Biosciences) flow cytometer. Data were analyzed using FlowJo software
(Tree Star).
Quantitative Real-Time PCR. RNA and cDNAwere prepared from sorted cells as
previously described (40). Real-time PCR was also performed as previously
described (6) on an i-Cycler (Bio-Rad). A cDNA clone encoding PLZF was a kind
gift from Albert Bendelac (University of Chicago, Chicago).
In Vitro Stimulation Assays. Wild-type and Itk/ TCRNK1.1, TCRNK1.1,
TCRCD4, and TCRCD4 subsets fromwere activated in vitrowith 10 g/ml
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of anti-TCR biotin (BD Pharmingen) for 72 hours, and supernatants were col-
lected and IL-4, IL-10, IL-13, and IFN were measured by cytometric bead array
(CBA) (BD Pharmingen). Cells used for quantitative PCR were stimulated for 10
and 20 hours and examined for IL-4 and IFN mRNA. For intracellular cytokine
staining, cells fromWT and Itk/mice were stimulated as previously described
(6). Cells were then surface stained for anti-TCR and anti-NK1.1, fixed, and
permeabilizedusingaCytofix/Cytopermkit (BDPharmingen) and stained for IL-4
and IFN. For ICOS,CD40LandOX40expressiononTcells, cellswerestimulated
for 24 hours with 10 g/ml anti-TCR. Cells were then surface stained with
anti-ICOS, anti-CD40L, and anti-OX40 antibodies.
Serum Analysis. Blood was collected fromWT, Tcrd/, Itk/, and Itk/Tcrd/
mice. Serumwas obtained by spinning the blood at 5000 rpm for 5 minutes and
removing the supernatant. Supernatants were analyzed by enzyme-linked im-
munosorbent assay (ELISA) for IgE.
Statistical Analysis. InStat software (GraphPad) was used to perform two-
tailed nonparametric Mann-Whitney tests.
For additional details, see SI Materials and Methods.
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